drugset / Trial / NCT06916702
A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and Women
RandomizedParallel-groupDouble-blindTreatment
Summary
Part A: The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3031185 in healthy male subjects following administration of multiple rising doses. Part B: The main objectives of Part B of this trial are to investigate safety, tolerability, and pharmacokinetics (PK) of BI 3031185 in healthy male subjects and female subjects of non-childbearing potential following oral administration of multiple doses of BI 3031185.
Timeline
- Start
- 2025-04-07
- Primary completion
- 2026-10-07
- Completion
- 2026-10-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3031185 | Unknown | — | Oral |
| Background | Midazolam | Small molecule | — | — |
Indications
No indication recorded.